APTAGEN Labs is a biotechnology and life-sciences company focused in synthetic biology. They develop ‘chemical antibodies’ called aptamers, with over 30 years of experience. Aptamers are target-recognition elements with high affinity and specificity against targets such as small molecules, protein biomarkers, cells, and tissues. Aptamers are an alternative platform to that of antibodies for diagnostic, therapeutic, and bio-industrial applications.